These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 17486245)

  • 1. Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe city (Argentina), over a mean follow-up of 21 years: parasitological, serological and clinical evolution.
    Fabbro DL; Streiger ML; Arias ED; Bizai ML; del Barco M; Amicone NA
    Rev Soc Bras Med Trop; 2007; 40(1):1-10. PubMed ID: 17486245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Longitudinal study and specific chemotherapy in children with chronic Chagas' disease, residing in a low endemicity area of Argentina].
    Streiger ML; del Barco ML; Fabbro DL; Arias ED; Amicone NA
    Rev Soc Bras Med Trop; 2004; 37(5):365-75. PubMed ID: 15361952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative controlled study on the use of benznidazole, nifurtimox and placebo, in the chronic form of Chagas' disease, in a field area with interrupted transmission. I. Preliminary evaluation].
    Coura JR; de Abreu LL; Willcox HP; Petana W
    Rev Soc Bras Med Trop; 1997; 30(2):139-44. PubMed ID: 9148337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.
    Sguassero Y; Cuesta CB; Roberts KN; Hicks E; Comandé D; Ciapponi A; Sosa-Estani S
    PLoS One; 2015; 10(10):e0139363. PubMed ID: 26436678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interventional study in the natural evolution of Chagas disease. Evaluation of specific antiparasitic treatment. Retrospective-prospective study of antiparasitic therapy].
    Gallerano RR; Sosa RR
    Rev Fac Cien Med Univ Nac Cordoba; 2000; 57(2):135-62. PubMed ID: 12934232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of the undetermined form of Chagas disease with nifortimox and benzonidazole].
    Ferreira Hde O
    Rev Soc Bras Med Trop; 1990; 23(4):209-11. PubMed ID: 2133586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection).
    Vallejo M; Reyes PP; Martinez Garcia M; Gonzalez Garay AG
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004102. PubMed ID: 33305846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolutive behavior towards cardiomyopathy of treated (nifurtimox or benznidazole) and untreated chronic chagasic patients.
    Fabbro De Suasnábar D; Arias E; Streiger M; Piacenza M; Ingaramo M; Del Barco M; Amicone N
    Rev Inst Med Trop Sao Paulo; 2000; 42(2):99-109. PubMed ID: 10810325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing antibody decline after chemotherapy of early chronic Chagas disease patients.
    Murphy N; Cardinal MV; Bhattacharyya T; Enriquez GF; Macchiaverna NP; Alvedro A; Freilij H; Martinez de Salazar P; Molina I; Mertens P; Gilleman Q; Gürtler RE; Miles MA
    Parasit Vectors; 2021 Oct; 14(1):543. PubMed ID: 34670602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the ELISA-F29 test as an early marker of therapeutic efficacy in adults with chronic Chagas disease.
    Fabbro D; Velazquez E; Bizai ML; Denner S; Olivera V; Arias E; Pravia C; Ruiz AM
    Rev Inst Med Trop Sao Paulo; 2013; 55(3):. PubMed ID: 23740013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nifurtimox therapy for Chagas disease does not cause hypersensitivity reactions in patients with such previous adverse reactions during benznidazole treatment.
    Pérez-Molina JA; Sojo-Dorado J; Norman F; Monge-Maillo B; Díaz-Menéndez M; Albajar-Viñas P; López-Vélez R
    Acta Trop; 2013 Aug; 127(2):101-4. PubMed ID: 23583863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of the chronic phase of the experimental infection by Trypanosoma cruzi with benzonidazole and nifurtimox].
    Andrade SG; Magalhães JB; Pontes AL
    Rev Soc Bras Med Trop; 1989; 22(3):113-8. PubMed ID: 2518608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial.
    Villar JC; Herrera VM; Pérez Carreño JG; Váquiro Herrera E; Castellanos Domínguez YZ; Vásquez SM; Cucunubá ZM; Prado NG; Hernández Y
    Trials; 2019 Jul; 20(1):431. PubMed ID: 31307503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypanocidal therapy among children infected by Trypanosoma cruzi. Serological and electrocardiographic changes over a mean twenty-five-years follow-up period.
    Suasnábar S; Olivera LV; Arias E; Bizai ML; Bottasso O; Arias E; Fabbro D
    Acta Trop; 2021 Oct; 222():106050. PubMed ID: 34302770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and developing therapeutic agents in the treatment of Chagas disease.
    Apt W
    Drug Des Devel Ther; 2010 Sep; 4():243-53. PubMed ID: 20957215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types.
    Andrade SG; Magalhães JB; Pontes AL
    Bull World Health Organ; 1985; 63(4):721-6. PubMed ID: 3936634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up of an asymptomatic Chagas disease population of children after treatment with nifurtimox (Lampit) in a sylvatic endemic transmission area of Colombia.
    Bianchi F; Cucunubá Z; Guhl F; González NL; Freilij H; Nicholls RS; Ramírez JD; Montilla M; Flórez AC; Rosas F; Saavedra V; Silva N
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003465. PubMed ID: 25723465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of an specific treatment for Trypanosoma cruzi in children, in the evolution of the indeterminate phase].
    Silveira CA; Castillo E; Castro C
    Rev Soc Bras Med Trop; 2000; 33(2):191-6. PubMed ID: 10881133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of chronic Chagas' disease with an association of nifurtimox and corticoid].
    Rassi A; Amato Neto V; de Siqueira AF; Ferriolli Filho F; Amato VS; Rassi GG; Rassi Junior A
    Rev Soc Bras Med Trop; 2002; 35(6):547-50. PubMed ID: 12612733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Trypanosoma cruzi infection in the undetermined phase. Experience and current guidelines of treatment in Argentina.
    Sosa Estani S; Segura EL
    Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():363-5. PubMed ID: 10677756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.